H P Parkman1, E K Hallinan2, W L Hasler3, G Farrugia4, K L Koch5, J Calles5, W J Snape6, T L Abell7, I Sarosiek8, R W McCallum8, L Nguyen9, P J Pasricha2, J Clarke2, L Miriel2, L Lee2, J Tonascia2, F Hamilton10. 1. Temple University, Philadelphia, PA, USA. 2. Johns Hopkins University, Baltimore, MD, USA. 3. University of Michigan, Ann Arbor, MI, USA. 4. Mayo Clinic, Rochester, MN, USA. 5. Wake Forest University, Winston-Salem, NC, USA. 6. California Pacific Medical Center, San Francisco, CA, USA. 7. University of Louisville, Louisville, KY, USA. 8. Texas Tech University, El Paso, TX, USA. 9. Stanford University, Palo Alto, CA, USA. 10. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Abstract
BACKGROUND: Nausea and vomiting are classic symptoms of gastroparesis. It remains unclear if characteristics of nausea and vomiting are similar in different etiologies of gastroparesis. The aims of this article were as follows: to describe characteristics of nausea and vomiting in patients with gastroparesis and to determine if there are differences in nausea and vomiting in diabetic (DG) and idiopathic gastroparesis (IG). METHODS: Gastroparetic patients enrolling in the NIDDK Gastroparesis Registry underwent assessment with history and questionnaires assessing symptoms, quality of life, and a questionnaire characterizing nausea and vomiting. KEY RESULTS: Of 159 gastroparesis patients (107 IG, 52 DG), 96% experienced nausea, whereas 65% experienced vomiting. Nausea was predominant symptom in 28% and vomiting was predominant in 4%. Nausea was severe or very severe in 41%. PAGI-SYM nausea/vomiting subscore was greater with increased vomiting severity, but not nausea severity in DG than IG. Nausea was related to meals in 71%; lasting most of the day in 41%. Increasing nausea severity was related to decreased quality of life. Nausea often preceded vomiting in 82% of patients and vomiting often relieved nausea in 30%. Vomiting was more common in DG (81%) compared to IG (57%; p = 0.004). Diabetic patients more often had vomiting in the morning before eating, during the night, and when not eating. CONCLUSIONS & INFERENCES: Nausea is present in essentially all patients with gastroparesis irrespective of cause and associated with decreased quality of life. In contrast, vomiting was more prevalent, more severe, and occurred more often in DG than IG. Thus, characteristics of vomiting differ in IG vs DG.
BACKGROUND:Nausea and vomiting are classic symptoms of gastroparesis. It remains unclear if characteristics of nausea and vomiting are similar in different etiologies of gastroparesis. The aims of this article were as follows: to describe characteristics of nausea and vomiting in patients with gastroparesis and to determine if there are differences in nausea and vomiting in diabetic (DG) and idiopathic gastroparesis (IG). METHODS: Gastroparetic patients enrolling in the NIDDK Gastroparesis Registry underwent assessment with history and questionnaires assessing symptoms, quality of life, and a questionnaire characterizing nausea and vomiting. KEY RESULTS: Of 159 gastroparesispatients (107 IG, 52 DG), 96% experienced nausea, whereas 65% experienced vomiting. Nausea was predominant symptom in 28% and vomiting was predominant in 4%. Nausea was severe or very severe in 41%. PAGI-SYM nausea/vomiting subscore was greater with increased vomiting severity, but not nausea severity in DG than IG. Nausea was related to meals in 71%; lasting most of the day in 41%. Increasing nausea severity was related to decreased quality of life. Nausea often preceded vomiting in 82% of patients and vomiting often relieved nausea in 30%. Vomiting was more common in DG (81%) compared to IG (57%; p = 0.004). Diabeticpatients more often had vomiting in the morning before eating, during the night, and when not eating. CONCLUSIONS & INFERENCES: Nausea is present in essentially all patients with gastroparesis irrespective of cause and associated with decreased quality of life. In contrast, vomiting was more prevalent, more severe, and occurred more often in DG than IG. Thus, characteristics of vomiting differ in IG vs DG.
Authors: Christine de la Loge; Elyse Trudeau; Patrick Marquis; Peter Kahrilas; Vincenzo Stanghellini; Nicholas J Talley; Jan Tack; Dennis A Revicki; Anne M Rentz; Dominique Dubois Journal: Qual Life Res Date: 2004-12 Impact factor: 4.147
Authors: G Tougas; E Y Eaker; T L Abell; H Abrahamsson; M Boivin; J Chen; M P Hocking; E M Quigley; K L Koch; A Z Tokayer; V Stanghellini; Y Chen; J D Huizinga; J Rydén; I Bourgeois; R W McCallum Journal: Am J Gastroenterol Date: 2000-06 Impact factor: 10.864
Authors: Henry P Parkman; Katherine Yates; William L Hasler; Linda Nguyen; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Kenneth L Koch; Thomas L Abell; Richard W McCallum; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton Journal: Gastroenterology Date: 2010-10-20 Impact factor: 22.682
Authors: D A Revicki; A M Rentz; D Dubois; P Kahrilas; V Stanghellini; N J Talley; J Tack Journal: Aliment Pharmacol Ther Date: 2003-07-01 Impact factor: 8.171
Authors: William L Hasler; Radoslav Coleski; William D Chey; Kenneth L Koch; Richard W McCallum; John M Wo; Braden Kuo; Michael D Sitrin; Leonard A Katz; Judy Hwang; John R Semler; Henry P Parkman Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-04-10 Impact factor: 4.052
Authors: Perry Orthey; Daohai Yu; Mark L Van Natta; Frederick V Ramsey; Jesus R Diaz; Paige A Bennett; Andrei H Iagaru; Roberto Salas Fragomeni; Richard W McCallum; Irene Sarosiek; William L Hasler; Gianrico Farrugia; Madhusudan Grover; Kenneth L Koch; Linda Nguyen; William J Snape; Thomas L Abell; Pankaj J Pasricha; James Tonascia; Frank Hamilton; Henry P Parkman; Alan H Maurer Journal: J Nucl Med Date: 2017-09-28 Impact factor: 10.057
Authors: Henry P Parkman; Laura A Wilson; William L Hasler; Richard W McCallum; Irene Sarosiek; Kenneth L Koch; Thomas L Abell; Ron Schey; Braden Kuo; William J Snape; Linda Nguyen; Gianrico Farrugia; Mandhusudan Grover; John Clarke; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha Journal: Dig Dis Sci Date: 2019-03-09 Impact factor: 3.199
Authors: William L Hasler; Laura A Wilson; Linda A Nguyen; William J Snape; Thomas L Abell; Kenneth L Koch; Richard W McCallum; Pankaj J Pasricha; Irene Sarosiek; Gianrico Farrugia; Madhusudan Grover; Linda A Lee; Laura Miriel; James Tonascia; Frank A Hamilton; Henry P Parkman Journal: Clin Gastroenterol Hepatol Date: 2018-10-13 Impact factor: 11.382
Authors: Henry P Parkman; Mark Van Natta; Goro Yamada; Madhusudan Grover; Richard W McCallum; Irene Sarosiek; Gianrico Farrugia; Kenneth L Koch; Thomas L Abell; Braden Kuo; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha Journal: Neurogastroenterol Motil Date: 2020-09-15 Impact factor: 3.598
Authors: Michael Camilleri; Victor Chedid; Alexander C Ford; Ken Haruma; Michael Horowitz; Karen L Jones; Phillip A Low; Seon-Young Park; Henry P Parkman; Vincenzo Stanghellini Journal: Nat Rev Dis Primers Date: 2018-11-01 Impact factor: 52.329
Authors: Henry P Parkman; Laura A Wilson; Katherine P Yates; Kenneth L Koch; Thomas L Abell; Richard W McCallum; Irene Sarosiek; Braden Kuo; Zubair Malik; Ron Schey; Robert J Shulman; Madhusudan Grover; Gianrico Farrugia; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha Journal: Neurogastroenterol Motil Date: 2021-01-25 Impact factor: 3.598